Toggle light / dark theme

As mentioned by H. Girard in the article at the link http://www.i-sis.org.uk/BW.php&h=AT2S6vfN4BKfFUss7oiAPJJ…w2jb-y0arw, in 1960, the CIA approved a proposal for a very sophisticated electroencephalography instrument that could be used to interpret brain activity, decipher thought content and obtain information whether a person would wish to disclose it or not. They also added to this a bibliography search with five objectives, the fifth termed €œTechniques for Activating the Human Organism by Remote Electronic Means €. This study became known later as MKULTRA subproject 119, with MKULTRA being the CIA €™s mind control program.

Documents that are related to MKULTRA were obtained by a FOIA request by John Marks who conducted research for his book “The Search For The Manchurian Candidate — The CIA and Mind Control, The Secret History of the Behavioral Sciences” (1979) published by W. Norton — paperback 1991, ISBN 0−393−30794−8. The author donated the documents to the National Security Archive of the George Washington University (http//www.seas.gwu.edu/nsarchive.html).

On Tuesday afternoon, NASA announced 19 new partnerships with 10 US companies to help bring more cutting-edge technologies closer to production use in spaceflight. There were a lot of useful engineering ideas here, such as precision landing systems and robotic plant farms, but perhaps the most intriguing one involved the rocket company SpaceX and two of NASA’s field centers—the Glenn Research Center in Ohio and the Marshall Space Flight Center in Alabama.

“SpaceX will work with Glenn and Marshall to advance technology needed to transfer propellant in orbit, an important step in the development of the company’s Starship space vehicle,” the NASA news release states. This is a significant announcement for reasons both technical and political.

Researchers at the Stanford University School of Medicine have discovered a new signal that cancers seem to use to evade detection and destruction by the immune system.

The scientists have shown that blocking this signal in mice implanted with allows immune cells to attack the cancers. Blocking other “don’t eat me” signals has become the basis for other possible anti– therapies.

Normally, immune cells called macrophages will detect cancer cells, then engulf and devour them. In recent years, researchers have discovered that proteins on the can tell macrophages not to eat and destroy them. This can be useful to help normal cells keep the immune system from attacking them, but cancer cells use these “don’t eat me” signals to hide from the immune system.

A newly developed technique that shows artery clogging fat-and-protein complexes in live fish gave investigators from Carnegie, Johns Hopkins University, and the Mayo Clinic a glimpse of how to study heart disease in action. Their research, which is currently being used to find new drugs to fight cardiovascular disease, is now published in Nature Communications.

Fat molecules, also called lipids, such as cholesterol and triglycerides are shuttled around the by a protein called Apolipoprotein-B, or ApoB for short. These complexes of lipid and protein are called lipoproteins but may be more commonly known as “bad cholesterol.”

Sometimes this fat-and-cholesterol ferrying apparatus stops in its tracks and embeds itself in the sides of blood vessels, forming a dangerous buildup. Called plaque, these deposits stiffen the wall of an artery and makes it more difficult for the heart to pump blood, which can eventually lead to a heart attack.